Literature DB >> 8993101

The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30.

M T King1.   

Abstract

While quality of life (QOL) assessment is becoming more common, interpreting the results remains problematic. This paper demonstrates an approach to developing clinically-based interpretations for QOL outcomes, using the QLQ-C30 as an example. The results from 14 published QLQ-C30 studies which group patients by performance status, weight loss, toxicity, extent or severity of disease are collated. Groups with lower clinical status generally have worse QOL. The largest differences are between performance status groups, and the smallest differences are between groups of patients with local disease and those with metastases. The physical and role scores have the largest ranges of means across patient groups, and show the largest differences between clinical groups, while the cognitive and emotional scores have the smallest ranges of means and differences. Sicker groups have larger score standard deviations than healthier groups. Relatively large and small means and differences, and corresponding effect sizes, are presented. Collectively, the results provide a sense of the relative sizes of means and of differences, and of the types of clinical groups which give rise to them, thereby providing clinically-based benchmarks by which to interpret QLQ-C30 results.

Entities:  

Mesh:

Year:  1996        PMID: 8993101     DOI: 10.1007/bf00439229

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  26 in total

Review 1.  Statistical versus quantitative significance in the socioeconomic evaluation of medicines.

Authors:  B J O'Brien; M F Drummond
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

Review 2.  Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons.

Authors:  M J Campbell; S A Julious; D G Altman
Journal:  BMJ       Date:  1995-10-28

Review 3.  Interpretation of quality of life changes.

Authors:  E Lydick; R S Epstein
Journal:  Qual Life Res       Date:  1993-06       Impact factor: 4.147

4.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

Authors:  E F Juniper; G H Guyatt; A Willan; L E Griffith
Journal:  J Clin Epidemiol       Date:  1994-01       Impact factor: 6.437

5.  The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique.

Authors:  V Sigurdardóttir; C Bolund; Y Brandberg; M Sullivan
Journal:  Qual Life Res       Date:  1993-06       Impact factor: 4.147

6.  Quality of life of cancer patients with different prognoses.

Authors:  G I Ringdal; K Ringdal; S Kvinnsland; K G Götestam
Journal:  Qual Life Res       Date:  1994-04       Impact factor: 4.147

7.  Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire.

Authors:  M J Hjermstad; S D Fossa; K Bjordal; S Kaasa
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

8.  Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.

Authors:  M J Moore; D Osoba; K Murphy; I F Tannock; A Armitage; B Findlay; C Coppin; A Neville; P Venner; J Wilson
Journal:  J Clin Oncol       Date:  1994-04       Impact factor: 44.544

9.  Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile.

Authors:  B Bergman; M Sullivan; S Sörenson
Journal:  Acta Oncol       Date:  1992       Impact factor: 4.089

10.  Quality of life measurement in patients with oesophageal cancer.

Authors:  J M Blazeby; M H Williams; S T Brookes; D Alderson; J R Farndon
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

View more
  152 in total

1.  Assessing the reliability of the EORTC QLQ-C30 in a sample of older African American and Caucasian adults.

Authors:  M E Ford; S L Havstad; C S Kart
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

2.  Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery.

Authors:  C Quinten; C Kenis; L Decoster; P R Debruyne; I De Groof; C Focan; F Cornelis; V Verschaeve; C Bachmann; D Bron; S Luce; G Debugne; H Van den Bulck; J C Goeminne; A Baitar; K Geboers; B Petit; C Langenaeken; R Van Rijswijk; P Specenier; G Jerusalem; J P Praet; K Vandenborre; M Lycke; J Flamaing; K Milisen; J P Lobelle; H Wildiers
Journal:  Qual Life Res       Date:  2018-12-03       Impact factor: 4.147

3.  Identifying changes in scores on the EORTC-QLQ-C30 representing a change in patients' supportive care needs.

Authors:  Claire F Snyder; Amanda L Blackford; Jonathan Sussman; Daryl Bainbridge; Doris Howell; Hsien Y Seow; Michael A Carducci; Albert W Wu
Journal:  Qual Life Res       Date:  2014-11-15       Impact factor: 4.147

4.  Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer.

Authors:  Nancy K Janz; Mahasin Mujahid; Paula M Lantz; Angela Fagerlin; Barbara Salem; Monica Morrow; Dennis Deapen; Steven J Katz
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

5.  Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population.

Authors:  Inger Schou; Øivind Ekeberg; Leif Sandvik; Marianne J Hjermstad; Cornelia M Ruland
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

6.  Socioeconomic status and quality of life in patients with locally advanced head and neck cancer.

Authors:  S Tribius; M S Meyer; C Pflug; H Hanken; C-J Busch; A Krüll; C Petersen; C Bergelt
Journal:  Strahlenther Onkol       Date:  2018-05-07       Impact factor: 3.621

7.  Estimating clinically significant differences in quality of life outcomes.

Authors:  Kathleen W Wyrwich; Monika Bullinger; Neil Aaronson; Ron D Hays; Donald L Patrick; Tara Symonds
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

Review 8.  The clinical significance of quality of life assessments in oncology: a summary for clinicians.

Authors:  Jeff A Sloan; Marlene H Frost; Rick Berzon; Amylou Dueck; Gordon Guyatt; Carol Moinpour; Mirjam Sprangers; Carol Ferrans; David Cella
Journal:  Support Care Cancer       Date:  2006-06-23       Impact factor: 3.603

9.  Development and validation of an instrument to measure the effects of a mistletoe preparation on quality of life of cancer patients: the Life Quality Lectin-53 (LQL-53) Questionnaire.

Authors:  Inge Kirchberger; Dieter Wetzel; Thomas Finger
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

10.  Development and evaluation of Korean version of Quality of Sexual Function (QSF-K) in healthy Korean women.

Authors:  Yumi Lee; Myong Cheol Lim; Yedong Son; Jungnam Joo; KiByung Park; Jung-Sup Kim; Dong Ock Lee; Sang-Yoon Park
Journal:  J Korean Med Sci       Date:  2014-05-30       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.